BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10882772)

  • 1. Pemphigus--decoding the cellular language of cutaneous autoimmunity.
    Edelson RL
    N Engl J Med; 2000 Jul; 343(1):60-1. PubMed ID: 10882772
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection against pemphigus foliaceus by desmoglein 3 in neonates.
    Wu H; Wang ZH; Yan A; Lyle S; Fakharzadeh S; Wahl JK; Wheelock MJ; Ishikawa H; Uitto J; Amagai M; Stanley JR
    N Engl J Med; 2000 Jul; 343(1):31-5. PubMed ID: 10882766
    [No Abstract]   [Full Text] [Related]  

  • 3. The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research.
    Warren SJ; Lin MS; Giudice GJ; Hoffmann RG; Hans-Filho G; Aoki V; Rivitti EA; Santos V; Diaz LA
    N Engl J Med; 2000 Jul; 343(1):23-30. PubMed ID: 10882765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations in enzyme-linked immunosorbent assays for antibodies against desmogleins 1 and 3 in patients with pemphigus.
    Bystryn JC; Akman A; Jiao D
    Arch Dermatol; 2002 Sep; 138(9):1252-3. PubMed ID: 12224997
    [No Abstract]   [Full Text] [Related]  

  • 6. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns.
    Parlowsky T; Welzel J; Amagai M; Zillikens D; Wygold T
    J Am Acad Dermatol; 2003 Apr; 48(4):623-5. PubMed ID: 12664033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSG 3 and DSG 1-ELISA as a specific diagnostic tool in oral bullous diseases.
    Sistig S; Lukac J; Vucicevic-Boras V; Malenica B
    Eur J Med Res; 2002 Apr; 7(4):181-2. PubMed ID: 12017158
    [No Abstract]   [Full Text] [Related]  

  • 9. A sensitive and restricted enzyme-linked immunosorbent assay for detecting a heterogeneous antibody population in serum from people suffering from a new variant of endemic pemphigus.
    Abréu-Vélez AM; Yepes MM; Patiño PJ; Bollag WB; Montoya F
    Arch Dermatol Res; 2004 Mar; 295(10):434-41. PubMed ID: 14730452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris.
    Jamora MJ; Jiao D; Bystryn JC
    J Am Acad Dermatol; 2003 Jun; 48(6):976-7. PubMed ID: 12789199
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of autoantibodies in patients with endemic pemphigus foliaceus (fogo selvagem).
    Nisihara RM; de Bem RS; Hausberger R; Roxo VS; Pavoni DP; Petzl-Erler ML; de Messias-Reason IJ
    Arch Dermatol Res; 2003 Aug; 295(4):133-7. PubMed ID: 12844225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of IgA autoantibodies to desmogleins by an enzyme-linked immunosorbent assay: the presence of new minor subtypes of IgA pemphigus.
    Hashimoto T; Komai A; Futei Y; Nishikawa T; Amagai M
    Arch Dermatol; 2001 Jun; 137(6):735-8. PubMed ID: 11405762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemphigus vulgaris: the other half of the story.
    Kalish RS
    J Clin Invest; 2000 Dec; 106(12):1433-5. PubMed ID: 11120748
    [No Abstract]   [Full Text] [Related]  

  • 14. Desmoglein autoimmunity in the pathogenesis of pemphigus.
    Gniadecki R
    Autoimmunity; 2006 Nov; 39(7):541-7. PubMed ID: 17101497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic pemphigus with circulating antibodies directed exclusively against the pemphigus vulgaris antigen desmoglein 3.
    Bouloc A; Joly P; Saint-Leger E; Wechsler J; Roujeau JC; Revuz J
    J Am Acad Dermatol; 2000 Oct; 43(4):714-7. PubMed ID: 11004638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3).
    Kubo A; Amagai M; Hashimoto T; Doi T; Higashiyama M; Hashimoto K; Yoshikawa K
    Br J Dermatol; 1997 Jul; 137(1):109-13. PubMed ID: 9274636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigus erythematosus: detection of anti-desmoglein-1 antibodies by ELISA.
    Gomi H; Kawada A; Amagai M; Matsuo I
    Dermatology; 1999; 199(2):188-9. PubMed ID: 10559598
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3).
    Memar O; Christensen B; Rajaraman S; Goldblum R; Tyring SK; Brysk MM; McCormick DJ; el-Zaim H; Fan JL; Prabhakar BS
    J Immunol; 1996 Oct; 157(7):3171-7. PubMed ID: 8816430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of pemphigus autoantibodies by IIF and ELISA tests in patients with pemphigus vulgaris and foliaceus and in healthy relatives.
    Torzecka JD; Narbutt J; Sysa-Jedrzejowska A; Waszczykowska E; Lukamowicz J; Pas HH
    Med Sci Monit; 2003 Dec; 9(12):CR528-33. PubMed ID: 14646976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Herpetiform pemphigus].
    Hashimoto T
    Ryoikibetsu Shokogun Shirizu; 2000; (31):261-3. PubMed ID: 11269073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.